1
00:00:02,520 --> 00:00:07,040
Speaker 1: Bloomberg Audio Studios, podcasts, radio news.

2
00:00:07,760 --> 00:00:10,240
Speaker 2: We also continue to monitor different things that come out

3
00:00:10,240 --> 00:00:11,800
Speaker 2: of the White House, and they certainly have made some

4
00:00:11,840 --> 00:00:15,680
Speaker 2: comments when it comes to healthcare pharmaceuticals in the United States,

5
00:00:15,720 --> 00:00:17,760
Speaker 2: which is one of the reasons we want to really

6
00:00:17,760 --> 00:00:20,479
Speaker 2: get to our next guest, good X good Rx. I

7
00:00:20,480 --> 00:00:23,320
Speaker 2: should say they recently reported earnings. Just a little bit

8
00:00:23,320 --> 00:00:26,000
Speaker 2: of background. Shares did jump after the price the drug

9
00:00:26,040 --> 00:00:29,159
Speaker 2: pricing comparison software company. They did boost their guidance for

10
00:00:29,320 --> 00:00:31,920
Speaker 2: just a Ibada for the full year, falling better than

11
00:00:31,920 --> 00:00:35,680
Speaker 2: expected results for the first quarter. We did see analysts saying,

12
00:00:36,000 --> 00:00:38,120
Speaker 2: some of them that the Ibada beat and raised as

13
00:00:38,159 --> 00:00:41,000
Speaker 2: a good start to twenty twenty five for the company.

14
00:00:41,120 --> 00:00:43,640
Speaker 2: Let's get into the business and how White House policies

15
00:00:43,920 --> 00:00:47,320
Speaker 2: are impacting good Rx. Wendy Barnes is president and CEO

16
00:00:47,600 --> 00:00:50,800
Speaker 2: of the company. She joins us from Charlotte, North Carolina.

17
00:00:51,000 --> 00:00:53,040
Speaker 2: The company, by the way, Marky Kaplin about one point

18
00:00:53,040 --> 00:00:56,200
Speaker 2: four billion shares two a year to date, or down

19
00:00:56,240 --> 00:00:59,040
Speaker 2: about twelve percent. They're down more than fifty percent though

20
00:00:59,160 --> 00:01:01,800
Speaker 2: in the past year. Wendy, good to have you here

21
00:01:01,840 --> 00:01:03,920
Speaker 2: with us. There's a lot going on in your space.

22
00:01:04,760 --> 00:01:06,800
Speaker 2: But I want to talk first and start with a

23
00:01:06,840 --> 00:01:10,760
Speaker 2: new initiative that you guys have actually introduced today. It's

24
00:01:10,800 --> 00:01:13,800
Speaker 2: called the Community Links program. Why did you do this?

25
00:01:13,840 --> 00:01:15,360
Speaker 2: What was the impetus for creating it?

26
00:01:16,920 --> 00:01:21,360
Speaker 1: Hi, Carol, thanks for having me appreciate the question. So

27
00:01:21,680 --> 00:01:23,280
Speaker 1: you know, I would say the company's been on a

28
00:01:23,319 --> 00:01:28,360
Speaker 1: multi year journey to best partner with retail pharmacies, with

29
00:01:28,480 --> 00:01:31,360
Speaker 1: community pharmacies really being at the top of that list,

30
00:01:31,959 --> 00:01:34,800
Speaker 1: and this is really the culmination of that work.

31
00:01:34,880 --> 00:01:37,400
Speaker 3: And so what you've referenced.

32
00:01:37,040 --> 00:01:40,600
Speaker 1: The good RX Community Link is a portal by which

33
00:01:40,640 --> 00:01:44,520
Speaker 1: community pharmacies sometimes referred to as independent pharmacies. So think

34
00:01:44,560 --> 00:01:47,840
Speaker 1: of those as really your non chain pharmacies. They can

35
00:01:47,920 --> 00:01:52,160
Speaker 1: be as small as a single pharmacy or some community

36
00:01:52,160 --> 00:01:55,400
Speaker 1: independent pharmacy owners have, you know, fifty seventy five or

37
00:01:55,440 --> 00:02:00,600
Speaker 1: one hundred locations, but largely they're run independent of broader

38
00:02:01,240 --> 00:02:05,760
Speaker 1: management philosophy, and this is our effort to contract directly

39
00:02:05,840 --> 00:02:12,520
Speaker 1: with these pharmacies in a cost plus reimbursement mechanism manner. Look,

40
00:02:12,800 --> 00:02:16,080
Speaker 1: it's not any new news to you or probably to

41
00:02:16,120 --> 00:02:20,120
Speaker 1: your listeners that pharmacies continue to be under reimbursement pressure,

42
00:02:20,720 --> 00:02:23,400
Speaker 1: and we believe that they are key partners in our

43
00:02:23,440 --> 00:02:27,520
Speaker 1: broader mission to make medications more affordable and accessible for

44
00:02:27,600 --> 00:02:30,560
Speaker 1: every American. And so this effort is really one in

45
00:02:30,639 --> 00:02:34,920
Speaker 1: which we're trying to bolster reimbursement for those independent pharmacies

46
00:02:34,919 --> 00:02:37,520
Speaker 1: such that they can work with us directly. And in

47
00:02:37,560 --> 00:02:41,320
Speaker 1: addition to that, we're giving them access to ninety plus

48
00:02:41,919 --> 00:02:46,959
Speaker 1: brand deals that we have secured with pharmaceutical manufacturers over

49
00:02:47,000 --> 00:02:49,679
Speaker 1: the last twelve to twenty four months, and those continue

50
00:02:49,720 --> 00:02:53,520
Speaker 1: to grow such that the reimbursement on those same drugs

51
00:02:53,919 --> 00:02:57,600
Speaker 1: is favorable to those pharmacies. It's really no secret that

52
00:02:57,639 --> 00:03:02,200
Speaker 1: pharmacies have long struggled to have a favorable margin profile

53
00:03:02,280 --> 00:03:05,480
Speaker 1: on many brands that they fill, and this too gives

54
00:03:05,520 --> 00:03:09,119
Speaker 1: access to those programs for those independent pharmacies.

55
00:03:09,680 --> 00:03:13,560
Speaker 4: Well, Wendy anecdotally speaking, as the large pharmacies and the

56
00:03:13,639 --> 00:03:17,839
Speaker 4: chains have come under pressure, whether it's over store closures

57
00:03:18,440 --> 00:03:21,280
Speaker 4: or different things happening just in the space, we've all

58
00:03:21,360 --> 00:03:23,280
Speaker 4: reported on what's happened in cities and the way that

59
00:03:23,560 --> 00:03:26,080
Speaker 4: some of these pharmacies have closed down in certain cities.

60
00:03:26,639 --> 00:03:30,880
Speaker 4: Are you seeing more people go to these independent pharmacies.

61
00:03:30,880 --> 00:03:33,120
Speaker 4: I mean, anecdotally speaking, I can say that certainly the

62
00:03:33,160 --> 00:03:36,000
Speaker 4: way my family has changed its behavior just thanks to

63
00:03:36,080 --> 00:03:39,640
Speaker 4: availability and what pharmacies tend to actually have what we're

64
00:03:39,640 --> 00:03:42,360
Speaker 4: looking for. But how have you seen that affect the

65
00:03:42,400 --> 00:03:43,480
Speaker 4: overall landscape.

66
00:03:44,800 --> 00:03:47,960
Speaker 1: I don't know that we've seen a meaningful shift to

67
00:03:48,040 --> 00:03:51,000
Speaker 1: independent from chain. I think there's still a pretty good

68
00:03:51,080 --> 00:03:56,000
Speaker 1: mix of grosser versus independent versus chain, and candidly, you know,

69
00:03:56,080 --> 00:03:59,360
Speaker 1: mail order slash digital pharmacy. I think at the end

70
00:03:59,400 --> 00:04:01,880
Speaker 1: of the day, what we see is in the seventy

71
00:04:01,920 --> 00:04:05,880
Speaker 1: plus odd thousand pharmacy options that we have as consumers

72
00:04:05,880 --> 00:04:08,800
Speaker 1: in the US that as a consumer, you just really

73
00:04:08,840 --> 00:04:11,600
Speaker 1: want to get your drugs on your own terms, whether

74
00:04:11,640 --> 00:04:15,440
Speaker 1: it's mail to your home with your preferred community pharmacist

75
00:04:15,920 --> 00:04:19,000
Speaker 1: or at a chain or grosser. And we pride ourselves

76
00:04:19,000 --> 00:04:22,080
Speaker 1: on working really with all pharmacy such that you can

77
00:04:22,120 --> 00:04:24,760
Speaker 1: get your drugs when and where you know you desire

78
00:04:24,839 --> 00:04:25,320
Speaker 1: to do so.

79
00:04:26,440 --> 00:04:28,800
Speaker 2: Do you see it all that the independent channel is shrinking.

80
00:04:28,839 --> 00:04:31,120
Speaker 2: We've certainly seen it with some of the big pharmacy chains, right,

81
00:04:31,120 --> 00:04:33,080
Speaker 2: We've talked about it, You've seen the headlines. But I'm

82
00:04:33,080 --> 00:04:35,880
Speaker 2: just curious when it comes to independence, Wendy, do you

83
00:04:35,960 --> 00:04:39,479
Speaker 2: see any shrinkage in terms of the number of outlets

84
00:04:39,480 --> 00:04:40,720
Speaker 2: that are out There are no.

85
00:04:42,640 --> 00:04:44,240
Speaker 1: You know, I will say in the numbers that we've

86
00:04:44,279 --> 00:04:46,200
Speaker 1: looked at over the last couple of years, there are

87
00:04:46,240 --> 00:04:49,279
Speaker 1: still a good number opening in any given month. I

88
00:04:49,279 --> 00:04:52,120
Speaker 1: will say in our book, with the pharmacies that we

89
00:04:52,200 --> 00:04:55,200
Speaker 1: work with, I haven't seen significant shrinkage.

90
00:04:55,320 --> 00:04:58,480
Speaker 3: But I think there are certainly other data sources.

91
00:04:58,080 --> 00:05:00,760
Speaker 1: That would suggest that there are a numbers of independent

92
00:05:00,839 --> 00:05:03,839
Speaker 1: and or community pharmacies that are closing in or selling

93
00:05:03,920 --> 00:05:07,360
Speaker 1: their business to other owners. But in our particular book,

94
00:05:07,360 --> 00:05:09,440
Speaker 1: it's held pretty study.

95
00:05:10,400 --> 00:05:14,480
Speaker 4: How have independence traditionally reacted to the program at GoodRx,

96
00:05:14,480 --> 00:05:17,400
Speaker 4: because it's our understanding they've been a little skeptical about it.

97
00:05:17,440 --> 00:05:19,800
Speaker 4: How do you make sure that they're embracing it rather

98
00:05:19,800 --> 00:05:21,760
Speaker 4: than treating it with skepticism.

99
00:05:22,080 --> 00:05:25,080
Speaker 1: Sure, well, I think you know, Look, it's early days,

100
00:05:25,160 --> 00:05:27,200
Speaker 1: to be clear, and we're going to be on a

101
00:05:27,279 --> 00:05:30,800
Speaker 1: journey here. Communication is going to be the biggest part

102
00:05:30,839 --> 00:05:34,080
Speaker 1: of this program, in addition to delivering what we said

103
00:05:34,080 --> 00:05:36,719
Speaker 1: we intend to deliver, which is fair economics.

104
00:05:37,320 --> 00:05:38,560
Speaker 3: Over the course of these.

105
00:05:38,400 --> 00:05:42,600
Speaker 1: Contractual agreements, as pharmacies agree to contract with this directly

106
00:05:42,960 --> 00:05:45,440
Speaker 1: and that again can all be conveyed through that portal

107
00:05:45,440 --> 00:05:47,360
Speaker 1: that we stood up this morning.

108
00:05:47,440 --> 00:05:48,720
Speaker 3: So for me, it's really.

109
00:05:48,520 --> 00:05:51,800
Speaker 1: Going to be about how we deliver on the reimbursement

110
00:05:51,839 --> 00:05:54,440
Speaker 1: mechanism through this partnership.

111
00:05:53,760 --> 00:05:57,119
Speaker 3: And I think, you know, the ongoing communication.

112
00:05:56,640 --> 00:06:01,000
Speaker 1: Will support how the pharmacy community embraces this over time.

113
00:06:01,120 --> 00:06:04,120
Speaker 1: You know, we've certainly been setting out communications early on.

114
00:06:04,960 --> 00:06:08,039
Speaker 1: We've been in dialogue with many independent pharmacy owners to

115
00:06:08,080 --> 00:06:11,000
Speaker 1: speak through the program. But I think at the end

116
00:06:11,040 --> 00:06:12,560
Speaker 1: of the day, it's really going to be the outcome

117
00:06:12,560 --> 00:06:14,440
Speaker 1: of the program and the economics.

118
00:06:13,880 --> 00:06:16,000
Speaker 3: That we deliver that we'll prove it out over time.

119
00:06:16,800 --> 00:06:18,120
Speaker 2: Well, that's why I want to kind of just dig

120
00:06:18,120 --> 00:06:20,320
Speaker 2: a little bit deeper, Wendy. You know, for this to

121
00:06:20,400 --> 00:06:24,000
Speaker 2: work for you guys, this new rollout, this Community Links program,

122
00:06:24,200 --> 00:06:26,680
Speaker 2: the economics have to work right for the independent pharmacy.

123
00:06:26,760 --> 00:06:29,479
Speaker 2: So I'm just curious what you can tell us how

124
00:06:29,480 --> 00:06:34,360
Speaker 2: the economics are different for the pharmacy that directly contacts

125
00:06:34,360 --> 00:06:37,800
Speaker 2: with GoodRx versus using maybe one of the pharmacy benefit

126
00:06:37,839 --> 00:06:41,160
Speaker 2: managers the PBMs and their networks to dispense a prescription.

127
00:06:41,320 --> 00:06:44,320
Speaker 2: What can you tell us more specifically about the economic

128
00:06:44,360 --> 00:06:49,880
Speaker 2: advantage for independent pharmacies to use your route versus going

129
00:06:49,920 --> 00:06:50,720
Speaker 2: to the PBMs.

130
00:06:51,760 --> 00:06:55,200
Speaker 1: Sure happy to do so. So it's really the agreement

131
00:06:55,279 --> 00:06:57,120
Speaker 1: directly with US is rooted.

132
00:06:56,880 --> 00:06:59,719
Speaker 3: On a NAEDEK plus reimbursement.

133
00:07:00,520 --> 00:07:03,920
Speaker 1: Is one of multiple benchmarks that is effectively a cost

134
00:07:04,080 --> 00:07:08,479
Speaker 1: mechanism that stands for national average drug acquisition cost, and

135
00:07:08,640 --> 00:07:11,600
Speaker 1: we are negotiating with independent pharmacies to do this with

136
00:07:11,680 --> 00:07:16,080
Speaker 1: that predicated as the baseline, plus an amount that keeps

137
00:07:16,120 --> 00:07:18,200
Speaker 1: them profitable on filling these claims.

138
00:07:18,240 --> 00:07:21,680
Speaker 3: So that's really the precursor, if you.

139
00:07:21,680 --> 00:07:24,960
Speaker 1: Will, and or the meat of how this agreement will work,

140
00:07:25,280 --> 00:07:29,800
Speaker 1: which again provides favorable economics to these pharmacies. The distinction, Carol,

141
00:07:29,840 --> 00:07:33,120
Speaker 1: as you called out to perhaps doing it through a

142
00:07:33,200 --> 00:07:36,880
Speaker 1: larger payer, when you think about how it works through

143
00:07:37,000 --> 00:07:40,679
Speaker 1: let's just say a larger PBM, there are multiple patient

144
00:07:40,720 --> 00:07:45,560
Speaker 1: pay slash cash networks through which an independent pharmacy can participate.

145
00:07:45,680 --> 00:07:48,360
Speaker 1: And when they're in that type of an algorithm, for

146
00:07:48,440 --> 00:07:52,200
Speaker 1: lack of better description, typically it's going to search for

147
00:07:54,160 --> 00:07:57,640
Speaker 1: not necessarily favorable margin for the pharmacy. And so there

148
00:07:57,680 --> 00:08:01,800
Speaker 1: would be times in their previous arrangement, whereby they may

149
00:08:01,800 --> 00:08:05,320
Speaker 1: not always have favorable economics to fill those prescriptions. And

150
00:08:05,360 --> 00:08:09,440
Speaker 1: by contracting directly, we are putting terms and conditions in

151
00:08:09,480 --> 00:08:13,280
Speaker 1: the agreement that allow them to have certainty around not

152
00:08:13,400 --> 00:08:17,000
Speaker 1: only the reimbursement, but also access to drugs that they're

153
00:08:17,040 --> 00:08:20,480
Speaker 1: not fulfilling today in patient pay programs. Again, that would

154
00:08:20,480 --> 00:08:22,960
Speaker 1: be the list of brands that I mentioned that I

155
00:08:23,000 --> 00:08:25,480
Speaker 1: believe are ninety plus at this point, that they're going

156
00:08:25,520 --> 00:08:28,400
Speaker 1: to have certainty around how they're reimbursed in this direct

157
00:08:28,440 --> 00:08:32,920
Speaker 1: engagement through us that they're not getting through their arrangements today.

158
00:08:33,760 --> 00:08:37,840
Speaker 4: Hey, Wendy, we're watching everything happening outside of Washington and

159
00:08:37,880 --> 00:08:40,200
Speaker 4: coming out of Washington really closely. We're expected to hear

160
00:08:40,240 --> 00:08:42,840
Speaker 4: from the President in just a few minutes. There's an

161
00:08:42,840 --> 00:08:46,160
Speaker 4: event happening in the Oval Office that's about a kid

162
00:08:46,200 --> 00:08:49,640
Speaker 4: account event scheduled. It was scheduled for two pm. We

163
00:08:49,720 --> 00:08:51,840
Speaker 4: understand the press pool has gathered. If the President starts

164
00:08:51,840 --> 00:08:54,640
Speaker 4: to take questions, we will certainly go there. In the meantime,

165
00:08:55,080 --> 00:08:58,640
Speaker 4: thinking about healthcare in the United States, it is inextricably

166
00:08:58,640 --> 00:09:03,400
Speaker 4: bound to politics, no question. If what the President calls

167
00:09:03,400 --> 00:09:06,560
Speaker 4: the big beautiful bill were to pass, we could see

168
00:09:06,559 --> 00:09:09,640
Speaker 4: at least, according to the CBO estimates of a dramatic

169
00:09:09,720 --> 00:09:14,640
Speaker 4: increase in the number of uninsured almost eight million. What

170
00:09:14,679 --> 00:09:17,040
Speaker 4: does that mean for your business and how much of

171
00:09:17,040 --> 00:09:20,679
Speaker 4: your business comes from medicaid and uninsured people today?

172
00:09:21,280 --> 00:09:26,000
Speaker 1: So interestingly, of the users who access our pricing on

173
00:09:26,200 --> 00:09:30,160
Speaker 1: any given day, roughly ninety percent actually have insurance today.

174
00:09:30,679 --> 00:09:34,640
Speaker 1: So I think there's a bit of a misperception that

175
00:09:34,760 --> 00:09:37,480
Speaker 1: the overwhelming number of consumers who use us in fact

176
00:09:37,480 --> 00:09:39,720
Speaker 1: don't have insurance, which is not the case.

177
00:09:40,360 --> 00:09:42,600
Speaker 3: Having said that, who does.

178
00:09:42,440 --> 00:09:46,520
Speaker 1: Come and look for pricing through our different platforms is

179
00:09:46,559 --> 00:09:50,720
Speaker 1: your consumer who's motivated to check for competitive pricing, whether

180
00:09:50,760 --> 00:09:53,640
Speaker 1: they have insurance or not. And we continue to be

181
00:09:53,679 --> 00:09:57,360
Speaker 1: the number one platform to look for the best price

182
00:09:57,440 --> 00:10:00,200
Speaker 1: deal that you can find on any particular medication. And

183
00:10:00,240 --> 00:10:02,880
Speaker 1: so as it pertains to what may or may not

184
00:10:03,040 --> 00:10:07,320
Speaker 1: pass in the bill, whether it's inclusive of Medicaid cuts

185
00:10:07,360 --> 00:10:12,200
Speaker 1: which continue to be advanced, and or other cuts that

186
00:10:12,240 --> 00:10:16,360
Speaker 1: would put pressure on your typical household income, what we

187
00:10:16,520 --> 00:10:19,559
Speaker 1: do know is that those should produce tailwinds for us

188
00:10:19,559 --> 00:10:22,960
Speaker 1: as a business. For consumers, whether they're insured or not,

189
00:10:23,200 --> 00:10:26,760
Speaker 1: but specifically as it relates to Medicaid cuts and the

190
00:10:26,880 --> 00:10:31,120
Speaker 1: number of individuals that may fall out of coverage. We

191
00:10:31,240 --> 00:10:33,960
Speaker 1: do believe that that presents an opportunity for us to

192
00:10:34,040 --> 00:10:38,719
Speaker 1: continue to support any American that really is struggling to

193
00:10:39,520 --> 00:10:40,839
Speaker 1: purchase their medications.

194
00:10:41,400 --> 00:10:44,080
Speaker 2: Wendy, just got thirty seconds. You know, the word that

195
00:10:44,080 --> 00:10:46,480
Speaker 2: we all use to describe the environment right now is uncertain.

196
00:10:47,040 --> 00:10:50,440
Speaker 2: There's a lot coming out, certainly leaders and CEOs. Just

197
00:10:50,480 --> 00:10:53,439
Speaker 2: in your industry too. You've got write Aid doing a bankruptcy.

198
00:10:53,520 --> 00:10:56,200
Speaker 2: You know, I think about the macro within your business

199
00:10:56,200 --> 00:10:59,199
Speaker 2: and just macro overall. Just got about twenty five seconds.

200
00:10:59,520 --> 00:11:00,840
Speaker 2: How do you look at the outlook?

201
00:11:00,920 --> 00:11:04,000
Speaker 3: Just quickly, you know the outlook?

202
00:11:04,040 --> 00:11:08,640
Speaker 1: You're right, turbulent is a fair description. Having said that,

203
00:11:09,200 --> 00:11:11,600
Speaker 1: businesses that stay the course and have a mission that

204
00:11:11,760 --> 00:11:14,439
Speaker 1: makes sense for the consumers in which we serve.

205
00:11:14,720 --> 00:11:15,839
Speaker 3: Will continue to thrive.

206
00:11:16,040 --> 00:11:19,400
Speaker 1: And our goal, of course is getting medication affordably and

207
00:11:19,440 --> 00:11:22,240
Speaker 1: effectively into the hands of every American who need it,

208
00:11:22,640 --> 00:11:24,280
Speaker 1: and we believe it will be in a position to

209
00:11:24,320 --> 00:11:25,199
Speaker 1: take advantage.

210
00:11:25,640 --> 00:11:27,960
Speaker 2: Wendy Barnes, President CEO OFRX